Herpes simplex and zoster.
D000367:Age Factors; D002493:Central Nervous System Diseases; D003231:Conjunctivitis; D003561:Cytarabine / Q000627:therapeutic use; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use; D004485:Eczema; D005260:Female; D005385:Fingers; D005831:Genital Diseases, Female; D005832:Genital Diseases, Male; D006561:Herpes Simplex / Q000151:congenital / Q000188:drug therapy / Q000276:immunology; D006562:Herpes Zoster / Q000188:drug therapy; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D007635:Keratitis, Dendritic; D008297:Male; D018139:Simplexvirus; D013256:Steroids / Q000009:adverse effects; D013280:Stomatitis
D013256:Steroids; D003561:Cytarabine; D007065:Idoxuridine; D004121:Dimethyl Sulfoxide